Alto Solutions has a total of 41 patents globally, out of which 9 have been granted. The United States of America is where Alto Solutions has filed the maximum number of patents, followed by Japan and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Alto Solutions.
Alto Solutions was founded in 2009 by Eric Satz. Alto Solutions develops software to manage investment and retirement assets. The Company offers platform that provide users with a simple interface to set up, invest with, and manage a diversified portfolio of alternative assets in start-ups, growth companies, real estate, loans, and digital assets.
Do read about some of the most popular patents of Alto Solutions which have been covered by us in this article and also you can find Alto Solutions patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Alto Solutions patent portfolio.
How many patents does Alto Solutions have?
Alto Solutions has a total of 41 patents globally. These patents belong to 3 unique patent families. Out of 41 patents, 1 patents are active.
How Many Patents did Alto Solutions File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Alto Solutions Applications Filed | Alto Solutions Patents Granted |
| 2004 | 1 | – |
| 2005 | 7 | – |
| 2006 | 16 | – |
| 2007 | 6 | – |
| 2008 | 1 | – |
| 2010 | 1 | 1 |
| 2012 | 1 | 2 |
| 2013 | 4 | 2 |
| 2014 | 2 | 2 |
| 2015 | 1 | 2 |
| 2016 | 1 | – |
How many Alto Solutions patents are Alive/Dead?
Worldwide Patents
How Many Patents did Alto Solutions File in Different Countries?
Countries in which Alto Solutions Filed Patents
| Country | Patent |
| United States of America | 12 |
| Japan | 8 |
| China | 6 |
| Europe | 5 |
| Canada | 4 |
| India | 2 |
Where are Research Centers of Alto Solutions Patents Located?
The Research Center of Alto Solutions Patents is the United States of America.
10 Best Alto Solutions Patents
US20090099060A1 is the most popular patent in the Alto Solutions portfolio. It has received 10 citations so far from companies.
Below is the list of 10 most cited patents of Alto Solutions:
| Publication Number | Citation Count |
| US20090099060A1 | 10 |
| US20090203636A1 | 7 |
| US20050113324A1 | 5 |
| CN101588805A | 5 |
| US8097595B2 | 4 |
| US7741296B2 | 3 |
| US8778906B2 | 3 |
| CN101443021A | 3 |
| CN101193643A | 3 |
| CN1925750A | 3 |
What Percentage of Alto Solutions US Patent Applications were Granted?
Alto Solutions (Excluding its subsidiaries) has filed 1 patent application at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.
Below are the key stats of Alto Solutions patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Alto Solutions?
| Law Firm | Total Applications | Success Rate |
| Wilson Sonsini Goodrich & Rosati | 1 | 100% |
List of Alto Solutions
| Alto Solutions Patents | Title |
| US8609623B2 | Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
| US8580753B2 | Modulation of telomere length in telomerase positive cells and cancer therapy |
| US8097595B2 | Modulation of telomere length in telomerase positive cells and cancer therapy |
| US7741296B2 | Modulation of telomere length in telomerase positive cells and cancer therapy |
| US9078901B2 | Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
| US8778906B2 | Modulation of line-1 reverse transcriptase |
| US20150094215A1 | Modulation of line-1 reverse transcriptase |
| US20050113324A1 | Modulation of line-1 reverse transcriptase |
| US20160000937A1 | Modulation of telomere length in telomerase positive cells and cancer therapy |
| US20140065072A1 | Modulation of Telomere Length in Telomerase Positive Cells and Cancer Therapy |
| US20090203636A1 | Prevention and Treatment of Cancer and Other Diseases |
| US20090099060A1 | Modulation of line-1 reverse transcriptase |
| EP2623105A3 | Modulation of line-1 reverse transcriptase |
| EP1885370A4 | Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
| EP1868615A4 | Modulation of telomere length in telomerase positive cells and cancer therapy |
| EP1713337A4 | Modulation of line-1 reverse transcriptase |
| EP2001488A4 | Prevention and treatment of cancer and other diseases |
| CN104997783A | Modulation of telomere length in telomerase positive cells and cancer therapy |
| CN104906105A | Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
| CN101588805A | Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
| CN101443021A | Prevention and treatment of cancer and other diseases |
| CN101193643A | Modulation of telomere length in telomerase positive cells and cancer therapy |
| CN1925750A | Modulation of LINE-1 reverse transcriptase |
| WO2006125166A9 | Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
| WO2007106561A3 | Prevention and treatment of cancer and other diseases |
| WO2006104975A2 | Modulation of telomere length in telomerase positive cells and cancer therapy |
| WO2005069880A3 | Modulation of line-1 reverse transcriptase |
| CA2602562C | Modulation of telomere length in telomerase positive cells and cancer therapy |
| CA2644297A1 | Prevention and treatment of cancer and other diseases |
| CA2609303A1 | Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
| CA2553265A1 | Modulation of line-1 reverse transcriptase |
| JP5571947B2 | Prevention and treatment of cancer and other diseases |
| JP5032129B2 | Line-1 modulation of the reverse transcriptase |
| JP2016175917A | Prevention and treatment of cancer and other diseases |
| JP2014144962A5 | Prevention and treatment of cancer and other disease |
| JP2013224953A5 | Modulation of telomere length in telomerase positive cells and cancer therapy |
| JP2013166787A | Use of composition for prevention and treatment of cancer |
| JP2008545658A | For the prevention and treatment of cancer, pharmacological modulation of telomere length in cancer cells |
| JP2008536822A | Regulation of telomere length and cancer therapy in telomerase-positive cells |
| IN2218KOLNP2006A | modulation of line-1 reverse transcriptase |
| INPCT2006KOL02218A | Modulation of line-1 reverse transcriptase |